News

Restore Hyper Wellness Tops Entrepreneur's 2025 Franchise Rankings

Restore Hyper Wellness Tops Entrepreneur's 2025 Franchise Rankings

Restore Hyper Wellness Achieves Exceptional Recognition

In an exciting development for the wellness industry, Restore Hyper Wellness, recognized as the largest provider of science-backed wellness therapies, has proudly secured the number one position in the Miscellaneous Personal-Care Businesses category of Entrepreneur’s coveted 2025 Franchise 500® Ranking. This prestigious title not only highlights Restore's excellence in the health and wellness sector but also underscores its commitment and innovative approach to personalized wellness solutions.

Understanding the Franchise 500 Ranking

Entrepreneur's Franchise 500 Ranking stands as the most comprehensive evaluation of franchise opportunities, assessing thousands of businesses based on essential criteria such as cost and fees, organizational size, growth potential, brand support, and overall strength. This rigorous vetting process ensures that only the most outstanding brands achieve recognition, and Restore Hyper Wellness's success in this sphere demonstrates its significant impact in the wellness community.

Dedicated Team Driving Success

What sets Restore Hyper Wellness apart is its extraordinary team, which includes passionate Nurses, Wellness Representatives, and Skin Health specialists dedicated to enhancing clients' health. This commitment to personalized care is complemented by a diverse range of services designed to meet individual wellness goals. From IV Drip Therapy, Cryotherapy, and Red Light Therapy to Infrared Saunas and Compression therapies, Restore provides various options tailored to suit clients' needs and preferences. Each therapy is carefully selected to promote optimal health and recovery.

Celebrating Team Effort and Mission

Steve Welch, CEO of Restore Hyper Wellness, expressed his gratitude and enthusiasm upon receiving this top recognition. "We are honored to be recognized as the leading brand in our category," he stated. "This achievement reflects the dedication and hard work of our franchise owners and HQ employees who are helping to redefine how people approach their health and longevity. Our mission is simple: to expand the limits of personal health and performance through personalized, science-backed therapies so our clients can do more of what they love." With more than 220 studios across the nation, Restore is making wellness accessible to everyone.

Overall Achievement in Franchise Opportunities

In addition to its top ranking in the Miscellaneous Personal-Care Businesses category, Restore Hyper Wellness has proudly positioned itself at #144 overall among the top 500 franchise businesses. This impressive ranking reflects Restore’s relentless growth, resilience, and creativity in a competitive and dynamic industry. Restore’s unwavering focus on personalized care and innovative therapies continues to set the standard for health and wellness franchises, ensuring a brighter future for both the brand and its clients.

About Restore Hyper Wellness

Established in 2015, Restore Hyper Wellness began its journey in Austin and has since made considerable strides in advancing personal health and performance. The company specializes in personalized, science-backed therapies that empower individuals to achieve their goals. With an extensive selection of wellness treatments, including Cryotherapy, Red Light Therapy, Infrared Saunas, IV Drip Therapy, and Niagen (NR) therapies, Restore stands at the forefront of the direct-to-consumer health market.

The brand's extensive reach through over 220 studios across the nation bolsters its status as the largest proactive healthcare provider for consumers, allowing for a wide array of therapeutic options consolidated under one roof. Customers can experience both expert guidance and cutting-edge services aimed at enhancing overall wellness.

Frequently Asked Questions

What services does Restore Hyper Wellness provide?

Restore Hyper Wellness offers a range of wellness therapies, including IV Drip Therapy, Cryotherapy, Infrared Sauna sessions, Red Light Therapy, and more, all designed to enhance personal health.

What is the Franchise 500 Ranking?

The Franchise 500 Ranking is an annual assessment by Entrepreneur that evaluates franchise businesses based on various criteria to determine the top opportunities in the market.

Who leads Restore Hyper Wellness?

Restore Hyper Wellness is led by CEO Steve Welch, who emphasizes personalized health care and the brand's commitment to innovative wellness solutions.

How many Restore Hyper Wellness studios are there?

Restore Hyper Wellness has more than 220 studios nationwide, making it the largest provider of proactive healthcare services for consumers.

When was Restore Hyper Wellness established?

Restore Hyper Wellness was founded in 2015 and has quickly expanded its presence and influence in the wellness industry since then.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

AIP Realty Trust Announces Successful Non-Brokered Offering

Updated Category News Views 177

AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...

Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care

Updated Category News Views 499

Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...

Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund

Updated Category News Views 84

KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....

Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action

Updated Category News Views 156

Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...

Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale

Updated Category News Views 205

Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...

Continue Reading